• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Blueprint Medicines Corporation - Common Stock (NQ: BPMC )

    90.46 UNCHANGED
    Streaming Delayed Price Updated: 1:00 PM EST, Dec 24, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 15
    Open 90.46
    Bid (Size) 36.37 (1)
    Ask (Size) 144.73 (2)
    Prev. Close 90.46
    Today's Range 90.46 - 90.46
    52wk Range 72.24 - 121.90
    Shares Outstanding 63,525,838
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Is NASDAQ:BPMC a Fit for high Growth Investing Strategies?
    Why the high growth investor may take a look at BLUEPRINT MEDICINES CORP (NASDAQ:BPMC). 
    Via Chartmill
    Blood Cancer-Focused Blueprint Medicines Could Be 'Attractive Target For Partnerships': Analyst
    JP Morgan initiates coverage on Blueprint Medicines, highlighting Ayvakit's significant growth, 2024 revenue forecast, and potential strategic opportunities. 
    Via Benzinga

    Performance

    YTD
    -0.67%
    -0.67%
    1 Month
    -3.63%
    -3.63%
    3 Month
    +3.98%
    +3.98%
    6 Month
    -12.95%
    -12.95%
    1 Year
    -0.39%
    -0.39%

    More News

    Read More
    Key Takeaways From Blueprint Medicines Analyst Ratings
    Via Benzinga
    Analyst Ratings For Blueprint Medicines
    Via Benzinga
    9 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    15 Analysts Have This To Say About Blueprint Medicines
    Via Benzinga
    Expert Ratings For Blueprint Medicines
    Via Benzinga
    Assessing Blueprint Medicines: Insights From 16 Financial Analysts
    Via Benzinga
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Blueprint Medicines Corporation and Encourages Investors to Contact the Firm
    From Schall Law
    Via GlobeNewswire
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    Unveiling 18 Analyst Insights On Blueprint Medicines
    Via Benzinga
    The Analyst Verdict: Blueprint Medicines In The Eyes Of 7 Experts
    Via Benzinga
    Decoding 6 Analyst Evaluations For Blueprint Medicines
    Via Benzinga
    (BPMC) - Analyzing Blueprint Medicines's Short Interest
    Via Benzinga
    BPMC Stock Earnings: Blueprint Medicines Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    C.H. Robinson Worldwide Posts Upbeat Results, Joins Avis Budget Group, Qualcomm, BorgWarner, Moderna And Other Big Stocks Moving Higher On Thursday
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Blueprint Medicines Corp. (NASDAQ: BPMC) Climbs to New 52-Week High
    Via Investor Brand Network
    Earnings Scheduled For February 15, 2024
    Via Benzinga
    Blueprint Medicines's Earnings Outlook
    Via Benzinga
    Cracking The Code: Understanding Analyst Reviews For Blueprint Medicines
    Via Benzinga
    Reliance Steel & Aluminum Posts Upbeat Earnings, Joins JFrog, AppLovin, Shake Shack And Other Big Stocks Moving Higher On Thursday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Blueprint Medicines Outranks 92% Of All Stocks. But This Could Be Its Undoing.
    Via Investor's Business Daily
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.